Vonoprazan Promising for Erosive Esophagitis Vonoprazan Promising for Erosive Esophagitis

The oral potassium-competitive acid blocker vonoprazan was noninferior and superior to the proton pump inhibitor lansoprazole for erosive esophagitis in a phase 3 trial.Medscape Medical News

Source: Medscape Gastroenterology Headlines - October 18, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news